# Proteomic analysis of tumor cell nuclear expulsion reveals significant cell adhesion and RNA binding programs in extracellular chromatin

**Authors:** Justin M. Gray, Woo Yong Park, Ronald J. Holewinski, Thorkell Andresson, Carmelo Carmona-Rivera, Mariana J. Kaplan, Li Yang

PMC · DOI: 10.1038/s41598-025-11807-z · Scientific Reports · 2025-08-01

## TL;DR

This study explores proteins in expelled cancer cell nuclei and finds they promote tumor growth through adhesion and RNA binding proteins.

## Contribution

The study identifies unique proteomic signatures of TuNEPs and their role in tumor progression.

## Key findings

- TuNEPs contain enriched cellular adhesion molecules like integrin and basigin (BSG).
- Proteins in TuNEPs show increased citrullination linked to RNA binding.
- TuNEP proteins differ from those in neutrophil-derived NETs.

## Abstract

Understanding mechanisms of cancer cell death and the resulting effect on disease progression is crucial in cancer biology and the insight will likely offer better options for therapeutic treatment. Nuclear expulsion occurs in apoptotic cancer cells in a peptidylarginine deiminase 4 (Padi4) dependent manner. The resulting tumor cell nuclear expulsion product (TuNEP) promotes the outgrowth of neighboring cancer cells through chromatin-bound protein complexes. It is not clear what the protein compositions and functionalities are in these TuNEPs. In this study, we performed extensive proteomic profiling and identified key TuNEP protein components from mouse and human breast cancer cells as well as human lung cancer cells (4T1, MDA-MB-231, and PC9). We further compared TuNEP- specific proteins with those from apoptotic bodies or NETs from neutrophils. We found an enrichment of cellular adhesion molecules as well as increased citrullination of proteins associated with RNA binding. We showed that cellular adhesion molecules integrin and basigin (BSG) promote the growth of tumor spheroids. Our work revealed the unique TuNEP protein components distinct from neutrophil-derived NETs and shed light on potential mechanisms by which these cancer cell-derived TuNEPs promote tumor progression.

The online version contains supplementary material available at 10.1038/s41598-025-11807-z.

## Linked entities

- **Genes:** PADI4 (peptidyl arginine deiminase 4) [NCBI Gene 23569], BSG (basigin (Ok blood group)) [NCBI Gene 682]
- **Proteins:** scb (scab), Bsg (Basigin)
- **Diseases:** breast cancer (MONDO:0004989), lung cancer (MONDO:0005138)
- **Species:** Mus musculus (taxon 10090), Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** FKBP1AP4 (FKBP prolyl isomerase 1A pseudogene 4) [NCBI Gene 2285] {aka FKBP12, FKBP1P4}, HNRNPH3 (heterogeneous nuclear ribonucleoprotein H3) [NCBI Gene 3189] {aka 2H9, HNRPH3}, SLC3A2 (solute carrier family 3 member 2) [NCBI Gene 6520] {aka 4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1}, H2AC20 (H2A clustered histone 20) [NCBI Gene 8338] {aka H2A, H2A-GL101, H2A/q, H2AFQ, HIST2H2AC}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, H1-2 (H1.2 linker histone, cluster member) [NCBI Gene 3006] {aka H1.2, H1C, H1F2, H1s-1, HIST1H1C}, HMGB1 (high mobility group box 1) [NCBI Gene 3146] {aka HMG-1, HMG1, HMG3, SBP-1}, SNRPD3 (small nuclear ribonucleoprotein D3 polypeptide) [NCBI Gene 6634] {aka SMD3, Sm-D3}, VIM (vimentin) [NCBI Gene 7431], ELANE (elastase, neutrophil expressed) [NCBI Gene 1991] {aka ELA2, GE, HLE, HNE, NE, PMN-E}, AGER (advanced glycosylation end-product specific receptor) [NCBI Gene 177] {aka RAGE, SCARJ1, sRAGE}, ITGA2 (integrin subunit alpha 2) [NCBI Gene 3673] {aka BR, CD49B, FMAIT3, GPIa, HPA-5, VLA-2}, RBMX (RNA binding motif protein X-linked) [NCBI Gene 27316] {aka HNRNPG, HNRPG, MRXS11, MRXSG, MRXSH, RBMXRT}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, H1-0 (H1.0 linker histone) [NCBI Gene 3005] {aka H1.0, H10, H1F0, H1FV}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, H2BC3 (H2B clustered histone 3) [NCBI Gene 3018] {aka H2B.1, H2B/f, H2BFF, HIST1H2BB}, S100A9 (S100 calcium binding protein A9) [NCBI Gene 6280] {aka 60B8AG, CAGB, CFAG, CGLB, L1AG, LIAG}, S100A4 (S100 calcium binding protein A4) [NCBI Gene 6275] {aka 18A2, 42A, CAPL, FSP1, MTS1, P9KA}, SLC7A5 (solute carrier family 7 member 5) [NCBI Gene 8140] {aka 4F2LC, CD98, D16S469E, E16, LAT1, MPE16}, ANXA2 (annexin A2) [NCBI Gene 302] {aka ANX2, ANX2L4, CAL1H, HEL-S-270, LIP2, LPC2}, HNRNPAB (heterogeneous nuclear ribonucleoprotein A/B) [NCBI Gene 3182] {aka ABBP1, HNRPAB}, MPO (myeloperoxidase) [NCBI Gene 4353], SRSF10 (serine and arginine rich splicing factor 10) [NCBI Gene 10772] {aka FUSIP1, FUSIP2, NSSR, PPP1R149, SFRS13, SFRS13A}, CD151 (CD151 molecule (Raph blood group)) [NCBI Gene 977] {aka EBS7, GP27, MER2, PETA-3, RAPH, SFA1}, SNRPD2 (small nuclear ribonucleoprotein D2 polypeptide) [NCBI Gene 6633] {aka SMD2, SNRPD1, Sm-D2}, H2AX (H2A.X variant histone) [NCBI Gene 3014] {aka H2A.X, H2A/X, H2AFX}, HNRNPM (heterogeneous nuclear ribonucleoprotein M) [NCBI Gene 4670] {aka CEAR, HNRNPM4, HNRPM, HNRPM4, HTGR1, NAGR1}, VCL (vinculin) [NCBI Gene 7414] {aka CMD1W, CMH15, HEL114, MV, MVCL, VINC}, BSG (basigin (Ok blood group)) [NCBI Gene 682] {aka 5F7, CD147, EMMPRIN, EMPRIN, HAb18G, OK}, PADI4 (peptidyl arginine deiminase 4) [NCBI Gene 23569] {aka PAD, PAD4, PADI5, PDI4, PDI5}, MACROH2A1 (macroH2A.1 histone) [NCBI Gene 9555] {aka H2A.y, H2A/y, H2AF12M, H2AFY, MACROH2A1.1, mH2A1}, CD9 (CD9 molecule) [NCBI Gene 928] {aka BTCC-1, DRAP-27, MIC3, MRP-1, TSPAN-29, TSPAN29}, H1-5 (H1.5 linker histone, cluster member) [NCBI Gene 3009] {aka H1, H1.5, H1B, H1F5, H1s-3, HIST1H1B}, ALYREF (Aly/REF export factor) [NCBI Gene 10189] {aka ALY, ALY/REF, BEF, REF, THOC4}, H2BP2 (H2B histone pseudogene 2) [NCBI Gene 338391] {aka HIST2H2BB}, PLAUR (plasminogen activator, urokinase receptor) [NCBI Gene 5329] {aka CD87, U-PAR, UPAR, URKR}, H2AC25 (H2A clustered histone 25) [NCBI Gene 92815] {aka H2AW, HIST3H2A}, SNRPG (small nuclear ribonucleoprotein polypeptide G) [NCBI Gene 6637] {aka SMG, Sm-G}, HNRNPA2B1 (heterogeneous nuclear ribonucleoprotein A2/B1) [NCBI Gene 3181] {aka HNRNPA2, HNRNPB1, HNRPA2, HNRPA2B1, HNRPB1, IBMPFD2}, H2BC21 (H2B clustered histone 21) [NCBI Gene 8349] {aka GL105, H2B, H2B-GL105, H2B.1, H2BE, H2BFQ}, LMNA (lamin A/C) [NCBI Gene 4000] {aka CDCD1, CDDC, CMD1A, CMT2B1, EMD2, FPL}, HMGB2 (high mobility group box 2) [NCBI Gene 3148] {aka HMG2}, ANXA1 (annexin A1) [NCBI Gene 301] {aka ANX1, LPC1}, S100A8 (S100 calcium binding protein A8) [NCBI Gene 6279] {aka 60B8AG, CAGA, CFAG, CGLA, CP-10, L1Ag}, H1-4 (H1.4 linker histone, cluster member) [NCBI Gene 3008] {aka H1.4, H1E, H1F4, H1s-4, HIST1H1E, RMNS}, ANXA5 (annexin A5) [NCBI Gene 308] {aka ANX5, CPB-I, ENX2, HEL-S-7, PP4, RPRGL3}, CASP9 (caspase 9) [NCBI Gene 842] {aka APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56}
- **Diseases:** bladder cancer (MESH:D001749), glioblastoma (MESH:D005909), infection (MESH:D007239), auto-immune disease (MESH:C538437), NETs (MESH:C536657), Tumor (MESH:D009369), LuAC (MESH:D000077192), inflammatory conditions (MESH:D007249), non-small cell lung cancer (MESH:D002289), metastasis (MESH:D009362), neutrophil (MESH:C564275), mammary tumor (MESH:D015674), TuNEP (MESH:D005935), TuNEPs (MESH:D007787), Breast cancer (MESH:D001943), lung and (MESH:D008171), RA (MESH:D001172), lung cancer (MESH:D008175), hepatocellular carcinoma (MESH:D006528), tumorigenic (MESH:D002471), tumorigenesis (MESH:D063646)
- **Chemicals:** BAPTA-AM (MESH:C070379), streptomycin (MESH:D013307), AP1903 (MESH:C423866), CO2 (MESH:D002245), Asn (MESH:D001216), Gln (MESH:D005973), EasyPep lysis buffer (-), lysine (MESH:D008239), amino acids (MESH:D000596), CaCl2 (MESH:D002122), formic acid (MESH:C030544), EGTA (MESH:D004533), methionine (MESH:D008715), Arg (MESH:D001120), A23187 (MESH:D000001), salt (MESH:D012492), Raptinal (MESH:C000611311), water (MESH:D014867), cysteine (MESH:D003545), dextran (MESH:D003911), penicillin (MESH:D010406), peptides (MESH:D010455), hydroxylamine (MESH:D019811), EDTA (MESH:D004492), SP-8356 (MESH:C000707760), PBS (MESH:D007854), DAPI (MESH:C007293), Ca++ (MESH:D002118)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Mycoplasma (genus) [taxon 2093]
- **Mutations:** F36V, AGC of 1
- **Cell lines:** PC9 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_B260), MDA-MB-231LM2 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_5998), SW-760 — Homo sapiens (Human), Nephropathic cystinosis, Finite cell line (CVCL_W236), Par — Rattus norvegicus (Rat), Transformed cell line (CVCL_D695), BrM2 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_VR36), EO771-LM — Mus musculus (Mouse), Malignant neoplasms of the mouse mammary gland, Cancer cell line (CVCL_GR23), PC9 lung cancer — Homo sapiens (Human), Lung squamous cell carcinoma, Cancer cell line (CVCL_3008), LuAC — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_WN45), RT-112 — Homo sapiens (Human), Bladder carcinoma, Cancer cell line (CVCL_1670), 4T1 — Mus musculus (Mouse), Malignant neoplasms of the mouse mammary gland, Cancer cell line (CVCL_0125), LM3 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_A5ER), MDA-MB-231 — Homo sapiens (Human), Breast adenocarcinoma, Cancer cell line (CVCL_0062)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12317086/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12317086/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12317086/full.md

---
Source: https://tomesphere.com/paper/PMC12317086